<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="067460-2018"
            EDITION="2018031">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-068508-001</RECEPTION_ID>
      <DELETION_DATE>20180523</DELETION_DATE>
      <FORM_LG_LIST>ES </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>31</NO_OJ>
         <DATE_PUB>20180214</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 031-067460</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:067460-2018:TEXT:ES:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>ES</LG_ORIG>
         <ISO_COUNTRY VALUE="ES"/>
         <IA_URL_GENERAL>http://www.contratacion.jcyl.es</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33652000">Antineoplastic and immunomodulating agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="ES418">Valladolid</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="ES418">Valladolid</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="ES511">Barcelona</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="ES300">Madrid</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">1496727.03</VALUE>
         </VALUES>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180212</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="3">Regional or local authority</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Иcпaния</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Антинеопластични средства и имуномодулатори</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Španělsko</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastika a imunomodulátory</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Spanien</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastiske og immunmodulerende midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Spanien</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastische und immunmodulierende Mittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ισπανία</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Spain</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastic and immunomodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>España</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Agentes antineoplásicos e inmunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Hispaania</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastilised ja immuunmoduleerivad ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Espanja</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Solunsalpaajat ja sytostaatit sekä immunomodulantit</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Espagne</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antinéoplasiques et immunomodulateurs</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Spáinn, an</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastic and immunomodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Španjolska</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastični lijekovi i imunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Spanyolország</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Daganatellenes és immunmodulátor szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Spagna</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Agenti antineoplastici e immunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Ispanija</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antinavikiniai vaistai ir imunomoduliatoriai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Spānija</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastiskie līdzekļi un imūnmodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Spanja</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Aġenti ta' l-antineoplastika u ta' l-immunomodulaturi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Spanje</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastische en immunomodulerende middelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Hiszpania</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Środki przeciwnowotworowe i immunomodulacyjne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Espanha</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplásicos e imunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Spania</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplazice şi imunomodulatoare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Španielsko</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastické a imunomodulačné činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Španija</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Zdravila z delovanjem na novotvorbe in imunomodulatorji</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Spanien</TI_CY>
            <TI_TOWN>Valladolid</TI_TOWN>
            <TI_TEXT>
               <P>Cytostatika/cytotoxiska medel och immunmodulerande medel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="ES">Hospital Clínico Universitario de Valladolid</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="ES">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Hospital Clínico Universitario de Valladolid</OFFICIALNAME>
               <NATIONALID>Q4777002I</NATIONALID>
               <ADDRESS>Avenida Ramón y Cajal, 3</ADDRESS>
               <TOWN>Valladolid</TOWN>
               <POSTAL_CODE>47003</POSTAL_CODE>
               <COUNTRY VALUE="ES"/>
               <PHONE>+34 983420022</PHONE>
               <E_MAIL>bnino@saludcastillayleon.es</E_MAIL>
               <FAX>+34 983420013</FAX>
               <n2016:NUTS CODE="ES418"/>
               <URL_GENERAL>http://www.contratacion.jcyl.es</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="REGIONAL_AUTHORITY"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>MEDICAMENTOS (FILGRASTIM, PEGFILGRASTIM, LIPEFILGRASTIM, INTERFERON BETA 1A Y 1B, PEGINTERFERON ALFA 1A Y 2B Y PEGINTERFERON BETA 1A)</P>
            </TITLE>
            <REFERENCE_NUMBER>2020006480</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33652000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>SUMINISTRO DE MEDICAMENTOS.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">1496727.03</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES418"/>
               <MAIN_SITE>
                  <P>Almacén de farmacia HCUV.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>SUMINISTRO DE MEDICAMENTOS.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Criterios de adjudicación que dependen de un juicio de valor</AC_CRITERION>
                  <AC_WEIGHTING>6</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Criterios evaluables mediante fórmulas</AC_CRITERION>
                  <AC_WEIGHTING>82</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES418"/>
               <MAIN_SITE>
                  <P>Almacén de farmacia HCUV.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>SUMINISTRO DE MEDICAMENTOS.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Criterios de adjudicación que dependen de un juicio de valor</AC_CRITERION>
                  <AC_WEIGHTING>6</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Criterios evaluables mediante fórmulas</AC_CRITERION>
                  <AC_WEIGHTING>82</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES418"/>
               <MAIN_SITE>
                  <P>Almacén de farmacia HCUV.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>SUMINISTRO DE MEDICAMENTOS.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Criterios de adjudicación que dependen de un juicio de valor</AC_CRITERION>
                  <AC_WEIGHTING>6</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Criterios evaluables mediante fórmulas</AC_CRITERION>
                  <AC_WEIGHTING>82</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES418"/>
               <MAIN_SITE>
                  <P>Almacén de farmacia HCUV.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>SUMINISTRO DE MEDICAMENTOS.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Criterios de adjudicación que dependen de un juicio de valor</AC_CRITERION>
                  <AC_WEIGHTING>6</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Criterios evaluables mediante fórmulas</AC_CRITERION>
                  <AC_WEIGHTING>82</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ES418"/>
               <MAIN_SITE>
                  <P>Almacén de farmacia HCUV.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>SUMINISTRO DE MEDICAMENTOS.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Criterios de adjudicación que dependen de un juicio de valor</AC_CRITERION>
                  <AC_WEIGHTING>6</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Criterios evaluables mediante fórmulas</AC_CRITERION>
                  <AC_WEIGHTING>82</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_AWARD_CONTRACT_WITHOUT_CALL>
               <D_ACCORDANCE_ARTICLE>
                  <D_TECHNICAL/>
               </D_ACCORDANCE_ARTICLE>
               <D_JUSTIFICATION>
                  <P>Es un procedimiento derivado del acuerdo marco nº 165/2016.</P>
               </D_JUSTIFICATION>
            </PT_AWARD_CONTRACT_WITHOUT_CALL>
            <CONTRACT_COVERED_GPA/>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>1</CONTRACT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-22</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Amgen, S.A.</OFFICIALNAME>
                     <TOWN>Barcelona</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES511"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1496727.03</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">4299.50</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>2</CONTRACT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-22</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Merck, S.L.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1496727.03</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">530837.94</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>3</CONTRACT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-22</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Biogen Spain, S.L.</OFFICIALNAME>
                     <TOWN>Madrid</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1496727.03</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">390732.76</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>5</CONTRACT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-22</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Bayer Hispania, S.L.</OFFICIALNAME>
                     <TOWN>San Joan Despí (Barcelona)</TOWN>
                     <COUNTRY VALUE="ES"/>
                     <n2016:NUTS CODE="ES300"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1496727.03</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">549900.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Dirección Gerencia del Hospital Clínico Universitario de Valladolid / Tribunal Administrativo Recursos Contractuales de Castilla y León</OFFICIALNAME>
               <TOWN>Valladolid</TOWN>
               <COUNTRY VALUE="ES"/>
            </ADDRESS_REVIEW_BODY>
            <DATE_DISPATCH_NOTICE>2018-02-12</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
